Insurance market closes week on positive note as AIICO gains over N1 billion w/w

0

The insurance market closed the week on a positive note as the ASI gained 0.43 basis point to close at 192.71 on the back of mixed performance in the sector.

At the close of the week ended 21st January, AIICO insurance was valued at N30 billion at N0.82 per share. The amount depicts a 2.5% gain over its previous closing price of 0.80 and a week on week gain of 3.8% from the valuation of N28.9 billion last week (depicting N1 billion gain).

Meanwhile, the market cap of all sixteen insurance firms listed on the NGX totalled N130.8 with AIICO insurance on the number one spot as the most capitalized while AXA Mansard and NEM follow with a valuation of N21 billion and N18.6 billion respectively.

Notably, the NGX closed on a positive note amidst sell-offs and buy-interests as the benchmark All-Share Index (ASI) appreciated by 15 basis points to close at 45,957.35 points, from the previous trading day and a Year-to-Date (YTD) return of 7.59% as market capitalization increased by N36.01 billion.

Highlights of insurers’ performance

  • AIICO up +0.02% to close at N0.82
  • AFRINSURE flat at N0.2
  • CHIPLC up +0.01% to close at N0.65
  • LASACO flat at N1.1
  • LINKASSURE down -0.01% to close at N0.56
  • SOVERENINS down -0.01 to close at N0.24
  • WAPIC flat at N0.49
  • SUNUASSUR down -0.01 to close at N0.49
  • MANSARD flat at N2.34
  • MBENEFIT up +0.01 to close at N0.27
  • NEM flat at N3.7
  • PRESTIGE Flat at N0.51
  • REGALINS down -0.02% to close at N0.42
  • CORNERST flat at N0.53
  • UNIVINSURE flat at N0.2
  • VERITASKAP flat at N0.21

Top Traded by Volume

  • SOVERENINS – 26,358,587 units
  • REGALINS – 7,982,480
  • MBENEFIT – 3,305,714
  • LINKASSURE – 998,646
  • AIICO – 965,151

Top Traded by Value

  • SOVERENINS at N6,067,701.68
  • REGALINS at N3,242,544.12
  • MANSARD at N1,449,303.99
  • MBENEFIT at N862,363.66
  • AIICO at N786,270.32
Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More